Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability and Food Effect of Verinurad Formulations in Healthy Men
NCT02448368Phase 1Completed
- Sponsor
- Ardea Biosciences, Inc.
- Start
- May 2015
- Primary completion
- Jun 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of verinurad in gout and hyperuricemia (8 arms), sponsored by Ardea Biosciences, Inc. Primary endpoints: Maximum Observed Plasma Concentration at Day 17, Time of Occurrence of Maximum Observed Concentration at Day 17 and 6 more. Started May 2015; status: completed.
02
Drugs
verinurad
03
Conditions
gouthyperuricemia
Beyond the preview
Go deeper on NCT02448368.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02448368.